The univariate Cox proportional hazards regression model determined that MGMT promoter methylation status was not a prognostic factor for patients with IDH-WT GBM (Table 2), whereas age and pre-/postoperative KPS were. This evidence concerns the gene IDH2 and glioblastoma.